This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Oventus Medical Delists from Australian Bourse MT
Crystalaid Manufacture Pty Ltd. completed the acquisition of Oventus Manufacturing Pty Ltd from Oventus Medical Limited for AUD 0.01 million. CI
Crystalaid Manufacture Pty Ltd. entered into an agreement to acquire Oventus Manufacturing Pty Ltd from Oventus Medical Limited for AUD 0.01 million CI
Oventus Medical Limited Announces Resignation of Melvyn Bridges as Director CI
Oventus Medical, Canadian Dental Clinical Partner Sign Exclusive Distribution Agreement MT
Oventus Medical Limited, Oventus Manufacturing Pty Ltd and Oventus Crm Pty Ltd Appoints Melvyn Bridges as Director CI
Oventus Medical Limited Announces Resignation of Chris Hart CI
Oventus Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2021 CI
Transcript : Oventus Medical Limited - Special Call
Oventus Medical Limited Announces CEO Succession Plan CI
Oventus Medical Limited Announces Executive Changes CI
Transcript : Oventus Medical Limited - Shareholder/Analyst Call
Transcript : Oventus Medical Limited, Q1 2022 Earnings Call, Nov 04, 2021
Oventus Medical Ltd Provides an Update on Clinical Trial and Regulatory Matters CI
Oventus Medical Limited Reports Earnings Results for the Full Year Ended June 30, 2021 CI
Transcript : Oventus Medical Limited - Shareholder/Analyst Call
Oventus Medical Limited Appoints John Cox as President and Chief Operating Officer of the Company CI
Oventus Medical Limited Announces Executive Changes CI
Oventus Medical Ltd Signs New Virtual Lab in Lab Agreement with Sleep Metrics CI
Oventus Medical : InHome Oxygen and Medical Equipment Enter Virtual Lab in Lab Agreement; Shares Jump 8% MT
Oventus Medical Ltd Signs First New Contract Under Oventus' Marketing Agency Agreement CI
Transcript : Oventus Medical Limited Presents at NWR Communications Virtual Resources Conference, Mar-18-2021 10:45 AM
Oventus Medical Limited Signs Agreements with Connect DME CI
Oventus Medical Limited Signs Distribution Agreement with Circadian Australia CI
Oventus Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2020 CI
Chart OVES MEDI
More charts
Oventus Medical Limited is an Australia-based medical device company. The Company is commercializing a treatment platform for obstructive sleep apnea (OSA) and snoring. The Company’s O2Vent devices are designed for any patient that is deemed appropriate for oral appliance therapy, but especially beneficial for the many people that suffer with nasal congestion, obstruction and mouth breathing. The Company’s product offerings include Oventus O2Vent Optima, O2Vent Optima, the ExVent and O2Vent Optima Mini. The Oventus O2Vent Optima product range provides relief to people who suffer snoring or mild to moderate OSA, and those who are unable to tolerate continuous positive airway pressure (CPAP) therapy. Its O2Vent Optima is an oral appliance, which features an integrated airway, using its own airway technology to treat the upper airway. It provides an uninterrupted airflow during sleep, as well as when a patient experiences nasal obstruction.
Sector
-
More about the company
  1. Stock Market
  2. Equities
  3. OVN Stock
  4. News OVES MEDI
  5. Oventus Medical, Canadian Dental Clinical Partner Sign Exclusive Distribution Agreement